A proposal for the management of type 2 diabetes mellitus (DM2) in primary care
DOI:
https://doi.org/10.17533/udea.rfnsp.11397Keywords:
type 2 diabetes mellitus, epidemiological surveillance, secondary prevention, health institutionsAbstract
Objective: to describe a surveillance system for type 2 diabetes mellitus (Surveillance System for Non-communicable diseases) while pointing to aspects that are considered basic for patient care at the first level units of the Secretarìa de Salud del Distrito Federal (Health Ministry of Mexico City). Methodology: the surveillance system was integrated with an epidemiological surveillance system which included prevention, early diagnosis, treatment, and control actions, as well as tasks supporting treatment adherence. This was linked to an information system (IS) whose design was based on the information requirements of the epidemiological surveillance system itself. Results: of all the people who attended the diagnostic confirmation process, 20.6% were tested positive for DM2 and 15% were admitted to treatment. In spite of the attempts to get people to return to their treatment, the greatest number of patient losses took place in the diagnostic confirmation and treatment entry stages. The is made it possible to obtain information on the evolution of each patient, identify cases of treatment abandonment, and begin to actively search for this person in order to enable their re-entry to the system. In addition, it could be provided with feedback. Discussion: when defining the population that will be subjected to surveillance, it is possible to differentiate incident from prevalent cases, and thus provide differential care individually and collectively under the focus of secondary prevention. Furthermore, other studies have found patient losses similar to those found in this research. This study favors early diagnosis and access to health services while generating information that is appropriate for the needs of the institution and of the people treated by it.
Downloads
References
(1). Ramlo-Halsed BA, Edelman SV. The natural History of Type 2 Diabetes: Practical Points to Consider in Developing Prevention and Treatment Strategies. Prim Care 1999; 26 (4): 771-789. DOI: https://doi.org/10.1016/S0095-4543(05)70130-5
(2). Gagliardino JJ., de la Hera M, Siri F. Evaluación de la calidad de la asistencia al paciente diabético en América Latina. Rev Panam Salud Pública/Pan Am J Public Health 2001; 10(5): 309-317.
(3). Nucci LB, Toscazo CM, Maia AL, Fonseca CD, Britto MM, Duncan BB, et al. A nationwide population screening program for dia-betes in Brazil. Rev Panam Salud Pública 2004; 16: 320-327. DOI: https://doi.org/10.1590/S1020-49892004001100005
(4). Secretaría de Salud. Programa de Acción: Diabetes Mellitus. [Internet] México: La Secretaría; 2001 [acceso 8 de abril de 2010]. Disponible en: www.salud.gob.mx/docprog/estrategia_3/diabe-tes_mellitus.pdf.
(5). Batista R, Landrove O, Bonet M, Feal P, Ramírez M. Sistema de vigilancia de enfermedades no transmisibles. Rev Cubana Hig Epidemiol 2000; 38(2): 77-92.
(6). Ramírez M, Rodríguez D, Landrove O, Santín M, Valdivia C, Serrano C, et al. Sistema de monitoreo y evaluación de la calidad de la atención médica en las enfermedades no transmisibles. Rev Cubana Hig Epidemiol 2001; 39(3): 157-163.
(7). Rascón-Pacheco RA, Santillana-Macedo MA, Romero-Arredondo MA, Rivera-Icedo BM, Romero-Cancio JA, Cota-Rembau AI. Sistema de Vigilancia epidemiológica para el paciente diabético. El uso de tecnología computacional en la calidad de la atención. Rev Sal Pub de Mex 2000; 43: 324-332. DOI: https://doi.org/10.1590/S0036-36342000000400007
(8). Mateo S, Regidor E. Sistemas de vigilancia de la salud pública: no pidamos peras al olmo. Gac Sanit 2003; 17(4): 327-331. DOI: https://doi.org/10.1157/13051028
(9). Knunti K. Uso of multiple methods to determine factors affecting quality of care o f patients with diabetes. Fam Pract 1999; 16: 489-494. DOI: https://doi.org/10.1093/fampra/16.5.489
(10). Salinas-Martínez. Necesidades de salud del diabético usuario del primer nivel de atención. Salud Pub de Méx 2001; 43(4): 324-334. DOI: https://doi.org/10.1590/S0036-36342001000400009
(11). Secretaría de Salud. Información para la rendición de cuentas. [Internet] México: La Secretaría; 2006. [acceso 4 de abril de 2010] Disponible en: http://evaluacion.salud.gob.mx.
(12). Garrido F, Puentes E. Unidades de primer nivel de atención en los Servicios Estatales de Salud. Evaluación 2008. México: Dirección General de Evaluación del Desempeño; 2009.
(13). Secretaría de Salud del Gobierno del Distrito Federal. Informe del trabajo de campo del SVEENT (Documento interno). México: La Secretaría; 2005.
(14). Secretaría de Salud Gobierno del Distrito Federal. Modificación a la Norma Oficial Mexicana NOM-015-SSA2-1994: para la prevención, tratamiento y control de la diabetes mellitus en la atención primaria para quedar como Norma Oficial Mexicana NOM-015-SSA2-1994: para la prevención, tratamiento y control de la diabetes. Diario Oficial de la Federación; México; 18 de enero de 2001.
(15). Gobierno del Estado de México. Guía del Procedimiento Operativo del Sistema de Información en Salud del Estado de México. México: El Gobierno; 2000.
(16). Programa Epi-Info versión 3.5.3. Organización Panamericana de la Salud, Centers for Disease Control and Prevention. Atlanta: OPS; 2000.
(17). Martínez, F. La práctica de la Vigilancia Epidemiológica en la Salud Pública. En: Vigilancia Epidemiológica. España: McGraw-Hill - Interamericana; 2004.
(18). Rodríguez-Morán M, Alvarado-Ruíz R, Morales-Franco G, Guerrero-Romero F. Combinación de un cuestionario autoaplicable con la determinación de glucosa capilar en el tamizaje de diabetes tipo 2. Rev Panam Salud Pública 2010; 27(3): 181-186. DOI: https://doi.org/10.1590/S1020-49892010000300005
(19). Chaudhry B, Wang J, Wu S, Malione M, Mojica W, Roth E, et al. Systematic Review: impacto of Eath information technology on quality, efficiency, and cost of Ann Intern Med 2006; 144 (10): 742-752. DOI: https://doi.org/10.7326/0003-4819-144-10-200605160-00125
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Maria G. Alvear G.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The contents of the articles are the responsibility of the authors
The editorial committee has editorial independence from the National School of Public Health "Héctor Abad Gómez" of the University of Antioquia.
The editorial committee is not responsible for aspects related to copying, plagiarism or fraud that may appear in the articles published in it.
When you are going to reproduce and disclose photographs or personal data in printed or digital format, informed consent is required. Therefore, this requirement is required of the author at the time of receipt of the manuscript.
Authors are responsible for obtaining the necessary permissions to reproduce any material protected by reproduction rights.
The authors preserve the moral rights and assign the economic rights that will correspond to the University of Antioquia, to publish it, distribute electronic copies, include them in indexing services, directories or national and international databases in Open Access, under the Creative Commons Attribution license -Not Commercial-Share Equal 4.0 International Commercial (CC BY-NC-SA) which allows others to distribute, remix, retouch, and create from the work in a non-commercial way, as long as the respective credit and license are granted. new creations under the same conditions.
The authors will sign the declaration of transfer of economic rights to the University of Antioquia, after the acceptance of the manuscript.
The editorial committee reserves the right to reject the articles whose authors do not offer satisfactory explanations about the contribution of each author, to meet the criteria of authorship in the submission letter. All authors must meet the four criteria of authorship according to ICMJE: "a) .- That there is a substantial contribution to the conception or design of the article or to the acquisition, analysis or interpretation of the data. b) That they have participated in the design of the research work or in the critical review of its intellectual content. c) .- That has been intervened in the approval of the final version that will be published.d). That they have the capacity to respond to all aspects of the article in order to ensure that issues related to the accuracy or integrity of any part of the work are adequately investigated and resolved. "
-- 
--
